An Ran, Strissel Pamela L, Al-Abboodi Majida, Robering Jan W, Supachai Reakasame, Eckstein Markus, Peddi Ajay, Hauck Theresa, Bäuerle Tobias, Boccaccini Aldo R, Youssef Almoatazbellah, Sun Jiaming, Strick Reiner, Horch Raymund E, Boos Anja M, Kengelbach-Weigand Annika
Laboratory for Tissue Engineering and Regenerative Medicine, Department of Plastic and Hand Surgery, University Hospital Erlangen, 91054 Erlangen, Germany.
Department of Plastic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Bioengineering (Basel). 2022 Jun 27;9(7):280. doi: 10.3390/bioengineering9070280.
Animal models are important tools to investigate the pathogenesis and develop treatment strategies for breast cancer in humans. In this study, we developed a new three-dimensional in vivo arteriovenous loop model of human breast cancer with the aid of biodegradable materials, including fibrin, alginate, and polycaprolactone. We examined the in vivo effects of various matrices on the growth of breast cancer cells by imaging and immunohistochemistry evaluation. Our findings clearly demonstrate that vascularized breast cancer microtissues could be engineered and recapitulate the in vivo situation and tumor-stromal interaction within an isolated environment in an in vivo organism. Alginate-fibrin hybrid matrices were considered as a highly powerful material for breast tumor engineering based on its stability and biocompatibility. We propose that the novel tumor model may not only serve as an invaluable platform for analyzing and understanding the molecular mechanisms and pattern of oncologic diseases, but also be tailored for individual therapy via transplantation of breast cancer patient-derived tumors.
动物模型是研究人类乳腺癌发病机制和制定治疗策略的重要工具。在本研究中,我们借助可生物降解材料(包括纤维蛋白、藻酸盐和聚己内酯)开发了一种新的人乳腺癌三维体内动静脉环模型。我们通过成像和免疫组织化学评估研究了各种基质对乳腺癌细胞生长的体内影响。我们的研究结果清楚地表明,可以构建血管化的乳腺癌微组织,并在体内生物体的隔离环境中重现体内情况和肿瘤-基质相互作用。基于其稳定性和生物相容性,藻酸盐-纤维蛋白混合基质被认为是用于乳腺肿瘤工程的一种非常强大的材料。我们提出,这种新型肿瘤模型不仅可以作为分析和理解肿瘤疾病分子机制和模式的宝贵平台,还可以通过移植乳腺癌患者来源的肿瘤来定制个体化治疗。